Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 21,817 | 22,717 | 31,939 | 34,402 | 30,264 |
| Income taxes - deferred | -1,300 | 3,812 | -696 | 138 | 1,136 |
| Accounts receivable | 1 | 2,370 | 738 | -266 | 1,044 |
| Accounts payable and accrued liabilities | 843 | -4,298 | 1,990 | 3,239 | -3,646 |
| Other Working Capital | 4,734 | 1,141 | 5,037 | 1,547 | -3,021 |
| Other Operating Activity | -8,965 | -17,739 | -23,219 | -22,118 | -9,348 |
| Operating Cash Flow | $17,130 | $8,003 | $15,789 | $16,942 | $16,429 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -205 | -15 | -41 | -45 | -47 |
| Net Acquisitions | 0 | -1,500 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,498 | 13,250 | -148 | -10,103 | -4,463 |
| Other Investing Activity | 0 | 13,250 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,703 | $11,735 | $-189 | $-10,148 | $-4,510 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 57,236 | N/A | 0 | 10,000 | N/A |
| Debt Repayment | -75,605 | -21,573 | -9,463 | -10,441 | -11,137 |
| Common Stock Repurchased | -1,799 | -600 | -1,552 | -998 | -47 |
| Dividend Paid | N/A | 0 | -2,398 | -4,962 | -5,122 |
| Other Financing Activity | -1,388 | -1,191 | -1,226 | -455 | 4,908 |
| Financing Cash Flow | $-21,556 | $-23,364 | $-14,639 | $-6,856 | $-11,398 |
| Exchange Rate Effect | 396 | -870 | 268 | -394 | 46 |
| Beginning Cash Position | 17,456 | 21,952 | 20,723 | 21,179 | 20,612 |
| End Cash Position | 11,723 | 17,456 | 21,952 | 20,723 | 21,179 |
| Net Cash Flow | $-6,129 | $-3,626 | $961 | $-62 | $521 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,130 | 8,003 | 15,789 | 16,942 | 16,429 |
| Capital Expenditure | -1,703 | -15 | -189 | -10,148 | -4,510 |
| Free Cash Flow | 15,427 | 7,988 | 15,600 | 6,794 | 11,919 |